Hyperglycaemia and risk of adverse perinatal outcomes: systematic review and meta-analysis.
Farrar D, Simmonds M, Bryant M, Sheldon TA, Tuffnell D, Golder S, Dunne F, Lawlor DA. · 2016
Read Hyperglycaemia and risk of adverse perinatal outcomes: systematic review and meta-analysis. by Farrar D, Simmonds M, Bryant M, Sheldon TA, Tuffnell D, Golder S, Dunne F, Lawlor DA. (2016) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc5021824.txt.
Introduction
Diane Farrar and seven co-authors pool data on blood sugar in pregnancy in The BMJ in 2016. High blood sugar harms babies and mothers, but most study has focused on women with diabetes. This review asked whether risk rises steadily with sugar levels even in women without any diabetes diagnosis, and whether a clear danger threshold exists. It combined 23 studies plus two birth cohorts, with up to 207,172 women.
Risk climbed in a straight line with sugar levels for several outcomes: caesarean birth, induced labor, overly large babies, and a stuck shoulder at delivery. No clear threshold appeared where risk suddenly jumped. Fasting sugar levels predicted outcomes more strongly than levels after a glucose drink. The steady climb complicates any cutoff for diagnosing pregnancy diabetes, and the authors note that lower cutoffs would bring many more women into extra care.
Catalog record
| CREATOR | Farrar D, Simmonds M, Bryant M, Sheldon TA, Tuffnell D, Golder S, Dunne F, Lawlor DA. |
|---|---|
| YEAR | 2016 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 52 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Hyperglycaemia and risk of adverse perinatal outcomes: systematic review and meta-analysis By Diane Farrar, Mark Simmonds, Maria Bryant, Trevor A Sheldon, Derek Tuffnell, Su Golder, Fidelma Dunne, Debbie A Lawlor Published in: The BMJ DOI: 10.1136/bmj.i4694 ABSTRACT Objectives To assess the association between maternal glucose concentrations and adverse perinatal outcomes in women without gestational or existing diabetes and to determine whether clear thresholds for identifying women at risk of perinatal outcomes can be identified. Design Systematic review and meta-analysis of prospective cohort studies and control arms of randomised trials. Data sources Databases including Medline and Embase were searched up to October 2014 and combined with individual participant data from two additional birth cohorts. Eligibility criteria for selecting studies Studies including pregnant women with oral glucose tolerance (OGTT) or challenge (OGCT) test results, with data on at least one adverse perinatal outcome. Appraisal and data extraction Glucose test results were extracted for OGCT (50 g) and OGTT (75 g and 100 g) at fasting and one and two hour post-load timings. Data were extracted on induction of labour; caesarean and instrumental delivery; pregnancy induced hypertension; pre-eclampsia; macrosomia; large for gestational age; preterm birth; birth injury; and neonatal hypoglycaemia. Risk of bias was assessed with a modified version of the critical appraisal skills programme and quality in prognostic studies tools. Results 25 reports from 23 published studies and two individual participant data cohorts were included, with up to 207 172 women (numbers varied by the test and outcome analysed in the meta-analyses). Overall most studies were judged as having a low risk of bias. There were positive linear associations with caesarean section, induction of labour, large for gestational age, macrosomia, and shoulder dystocia for all glucose exposures across the distribution of glucose concentrations. There was no clear evidence of a threshold effect. In general, associations were stronger for fasting concentration than for post-load concentration. For example, the odds ratios for large for gestational age per 1 mmol/L increase of fasting and two hour post-load glucose concentrations (after a 75 g OGTT) were 2.15 (95% confidence interval 1.60 to 2.91) and 1.20 (1.13 to 1.28), respectively. Heterogeneity was low between studies in all analyses. Conclusions This review and meta-analysis identified a large number of studies in various countries. There was a graded linear association between fasting and post-load glucose concentration across the whole glucose distribution and most adverse perinatal outcomes in women without pre-existing or gestational diabetes. The lack of a clear threshold at which risk increases means that decisions regarding thresholds for diagnosing gestational diabetes are somewhat arbitrary. Research should now investigate the clinical and cost-effectiveness of applying different glucose thresholds for diagnosis of gestational diabetes on perinatal and longer term outcomes. Systematic review registration PROSPERO CRD42013004608 INTRODUCTION Gestational diabetes, defined as hyperglycaemia first identified during pregnancy, increases the risk of a range of adverse perinatal outcomes including macrosomia and caesarean section.1 There is also growing evidence that the longer term health of the mother and infant could be adversely affected.2 3 4 The primary aim of diagnosing gestational diabetes is to identify women and infants at risk of short or longer term adverse outcomes. While traditionally the primary aim was to identify women at risk of type 2 diabetes, the recent International Association of Diabetes and Pregnancy Study Groups (IADPSG) proposed glucose thresholds were calculated to identify adverse perinatal outcomes with the ultimate aim of preventing future obesity in offspring.5 Although treatment of gestational diabetes can reduce the risk of perinatal outcomes,6 7 there is uncertainty regarding the optimal glucose threshold (at oral glucose tolerance testing (OGTT)) that should define gestational diabetes. Findings from the Hyperglycaemia and Adverse Pregnancy Outcomes (HAPO) study showed graded linear increases in large for gestational age, large skinfold thicknesses, high cord blood C peptide, and several other important perinatal outcomes, across the whole distribution of fasting and post-load glucose in women without existing diabetes or gestational diabetes.8 Given the lack of any clear threshold for increased risk, the IADPSG calculated thresholds using the HAPO data as the glucose values at which odds for birthweight, cord C peptide, and percent body fat above the 90th centile reached 1.75 times the estimated odds of these outcomes above mean glucose values.5 The IADPSG criteria for diagnosing gestational diabetes have been endorsed by the World Health Organization (WHO)9 and more recently by the International Federation of Gynecology and Obstetrics (FIGO).10 Not all countries or institutions, such as UK National Institute of Health and Care Excellence (NICE)11 and American College of Obstetrics and Gynaecology,12 have endorsed these criteria. Though the HAPO study is large, multicentred, and well conducted, it did not present results by country, and the shape and magnitude of the association between glycaemia and pregnancy outcomes could differ in different populations, for example by ethnicity. The question of whether the shape and magnitude of the association would be seen in all populations remains unanswered. We recently analysed a cohort of white British and south Asian women13 and found that the HAPO/IADPSG findings were replicated in the white British women, but in the south Asian women our results suggested that lower fasting and post-load glucose concentrations are required to achieve the same odds of identifying adverse perinatal outcomes. We also noted that the IADPSG thresholds for post-load glucose were importantly influenced by the fact that the post-load threshold used by HAPO to exclude women with gestational diabetes was much higher than that currently used in clinical practice and also at the time of the start of that study. A further issue is whether using a different set of outcomes would produce different diagnostic thresholds to those selected by the IADPSG, as, even with linear relations, the slopes are likely to differ and hence the threshold at which a given odds ratio would occur will differ between outcomes. In particular the IADPSG did not consider important clinical outcomes such as hypertensive disorders of pregnancy, the requirement for induction of labour, caesarean section, and whether the infant suffered from shoulder dystocia, neonatal hypoglycaemia, and/or required admission to neonatal intensive care, which are key clinical criteria that clinicians and pregnant women are concerned about. We conducted a systematic search of the literature to examine the available evidence and the degree to which these questions have been examined in different populations. Wherever possible we pooled data and conducted appropriate sensitivity analyses to investigate any potential study and population effects. METHODS We conducted this systematic review and meta-analysis in accordance with Cochrane Systematic Reviews14 and the Centre for Reviews and Dissemination recommendations15 and have reported our findings according to PRISMA reporting guidelines. Search strategy Searches were undertaken, and three reviewers (DF, MS and SG) independently assessed the literature for inclusion. Data from eligible studies were combined with data from two additional birth cohort studies: the Born in Bradford cohort13 and the Atlantic Diabetes in Pregnancy cohort (F Dunne, personal communication), for which we also had access to individual participant data. Identification of studies from systematic review We searched the literature in September 2013 and October 2014 using Medline and Medline in-Process, Embase, CINAHL Plus, the Cochrane Central Register of Controlled Trials (CENTRAL), Cochrane Database of Systematic Reviews (CDSR), Database of Abstracts of Reviews of Effects